Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
App-based biometric coaching associated with improved clinician well-being and reduced burnout
Burnout among health care professionals has become a persistent and pressing issue, especially in high-stress…
Emoji use in clinical notes is rare but varied, analysis of 218 million records finds
Emojis and emoticons — small digital symbols used to express emotions, ideas, and concepts —…
Phase III PATINA study results published
Alliance Foundation Trials, LLC (AFT) today announced the publication of the pivotal phase III PATINA…
Lower dose of abiraterone acetate as effective for prostate cancer treatment
- Good prognosis for men with prostate cancer treated according to guidelines
- Draft screening guidelines are a win, but prostate cancer patients in regional areas are still left behind on treatment options
- Botox mitigates debilitating dry mouth in prostate cancer patients receiving radiopharmaceutical therapy
The Oncology Journal Club Podcast 3: Immunotherapy, Microbiome, Sexual Health and Quality of Life Post-Treatment
The Oncology Podcast, part of The Oncology Network, is proud to present Episode 3 in the second series of The Oncology Journal…
ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC
- ASTRO 2025: Pulsed low dose rate chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with oesophageal cancer and non-small cell lung cancer
- ASTRO 2025: Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice – (vs once -) daily radiation
- Not all ALK fusions act the same: Variants influence treatment success in lung cancer
How AI could dramatically improve cancer patients’ prognosis
Frédéric Jallat, PhD, ESCP Business School With 1.2 million deaths in the 2020, or 23% of the total number of…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.